Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (not Standard BioTools Inc.) on January 11, 2022. The filing announces the issuance of a press release containing preliminary financial results for the fourth quarter and full year ended December 31, 2021.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus prior periods. It serves solely to notify the market of the availability of the preliminary results for Q4 and full-year 2021.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on unusual items. The document explicitly states that the information is "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, meaning it is not incorporated by reference into future filings unless specifically cited.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net loss, cash position) by reviewing Exhibit 99.1 (the press release) attached to the full filing.
- Confirm the company name is Fluidigm Corporation (Ticker: FLDM), noting the discrepancy with the metadata label "Standard BioTools Inc."
- Check for any subsequent filings that may incorporate the furnished results by reference.
- Review the full press release for any forward-looking statements or guidance not captured in this summary.